Education
About Us
Working with TipRanks
Follow Us
Cingulate Inc (CING)
NASDAQ:CING
CING Stock Chart & Stats
Day’s Range― - ―
52-Week Range$3.02 - $6.01
Previous CloseN/A
Volume136.88K
Average Volume (3M)144.67K
Market Cap
$20.62M
Enterprise Value$15.55M
Total Cash (Recent Filing)$8.90M
Total Debt (Recent Filing)$6.58M
Price to Earnings (P/E)―
Beta5.23
Next Earnings
Nov 17, 2025EPS Estimate
-0.88Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.09
Shares Outstanding5,412,523
10 Day Avg. Volume188,991
30 Day Avg. Volume144,672
Financial Highlights & Ratios
PEG Ratio0.01
Price to Book (P/B)2.52
Price to Sales (P/S)0.00
P/FCF Ratio-1.01
Enterprise Value/Market Cap0.75
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda-0.89
Forecast
1Y Price Target
$25.00Price Target Upside556.17% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
Bulls Say, Bears Say
Bulls Say
Market PotentialConsidering the ongoing stimulant shortages and that CTx-1301 only requires one daily dose, the commercial opportunity for Cingulate is considered attractive.
Partnership And CommercializationCingulate announced a partnership with Bend Bio Sciences to be the exclusive commercial manufacturer of CTx-1301 in the U.S. through 2028, assuming approval.
Regulatory ProgressCingulate announced it received a PDUFA fee waiver from the FDA worth ~$4.3M for its first NDA filing for CTx-1301 for treating Attention Deficit/Hyperactivity Disorder (ADHD), paving the way for its NDA filing.
Bears Say
Regulatory RisksShares are trading down due to investor concerns around regulatory risks, including potential concerns about the Phase 3 data, commercial risks, or potential delays by the FDA.
Cingulate Inc News
CING FAQ
What was Cingulate Inc’s price range in the past 12 months?
Cingulate Inc lowest stock price was $3.02 and its highest was $6.01 in the past 12 months.
What is Cingulate Inc’s market cap?
Cingulate Inc’s market cap is $20.62M.
When is Cingulate Inc’s upcoming earnings report date?
Cingulate Inc’s upcoming earnings report date is Nov 17, 2025 which is in 49 days.
How were Cingulate Inc’s earnings last quarter?
Cingulate Inc released its earnings results on Aug 19, 2025. The company reported -$1.09 earnings per share for the quarter, missing the consensus estimate of -$0.915 by -$0.175.
Is Cingulate Inc overvalued?
According to Wall Street analysts Cingulate Inc’s price is currently Undervalued.
Does Cingulate Inc pay dividends?
Cingulate Inc does not currently pay dividends.
What is Cingulate Inc’s EPS estimate?
Cingulate Inc’s EPS estimate is -0.88.
How many shares outstanding does Cingulate Inc have?
Cingulate Inc has 5,412,523 shares outstanding.
What happened to Cingulate Inc’s price movement after its last earnings report?
Cingulate Inc reported an EPS of -$1.09 in its last earnings report, missing expectations of -$0.915. Following the earnings report the stock price went down -9.615%.
Which hedge fund is a major shareholder of Cingulate Inc?
Among the largest hedge funds holding Cingulate Inc’s share is GoalVest Advisory LLC. It holds Cingulate Inc’s shares valued at 0.
Company Description
Cingulate Inc
Cingulate Inc., a clinical-stage biopharmaceutical company, focuses on the development of product candidates for the treatment of attention-deficit/hyperactivity disorder. The company's lead product candidates are CTx-1301 (dexmethylphenidate), which is in phase 3 clinical trial, and CTx-1302 (dextroamphetamine) for the treatment of attention-deficit/hyperactivity disorders. It also focuses on developing CTx-2103 for the treatment of anxiety disorders. The company was founded in 2012 and is headquartered in Kansas City, Kansas.
CING Stock 12 Month Forecast
Average Price Target
$25.00
▲(556.17% Upside)
Technical Analysis
Bio Green Med Solution
―
NanoViricides
―
Enlivex
―
FibroBiologics, Inc.
―
Boundless Bio Inc.
―
Ownership Overview
37.48% Insiders
1.11% Mutual Funds
0.43% Other Institutional Investors
60.48% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---